Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems

Approaches to increase the efficiency in developing drugs and diagnostics tools, including new drug delivery and diagnostic technologies, are needed for improved diagnosis and treatment of major diseases and health problems such as cancer, inflammatory diseases, chronic wounds, and antibiotic resistance. Development within several areas of research ranging from computational sciences, material sciences, bioengineering to biomedical sciences and bioimaging is needed to realize innovative drug development and diagnostic (DDD) approaches. Here, an overview of recent progresses within key areas that can provide customizable solutions to improve processes and the approaches taken within DDD is provided. Due to the broadness of the area, unfortunately all relevant aspects such as pharmacokinetics of bioactive molecules and delivery systems cannot be covered. Tailored approaches within (i) bioinformatics and computer-aided drug design, (ii) nanotechnology, (iii) novel materials and technologies for drug delivery and diagnostic systems, and (iv) disease models to predict safety and efficacy of medicines under development are focused on. Current developments and challenges ahead are discussed. The broad scope reflects the multidisciplinary nature of the field of DDD and aims to highlight the convergence of biological, pharmaceutical, and medical disciplines needed to meet the societal challenges of the 21st century.

[1]  Dan Jones Steps on the road to personalized medicine , 2007, Nature Reviews Drug Discovery.

[2]  Jixi Zhang,et al.  The viability of mesoporous silica nanoparticles for drug delivery. , 2015, Therapeutic delivery.

[3]  Maren Preis,et al.  Perspective: Concepts of printing technologies for oral film formulations. , 2015, International journal of pharmaceutics.

[4]  William B. Liechty,et al.  Polymers for drug delivery systems. , 2010, Annual review of chemical and biomolecular engineering.

[5]  K. Fidelis,et al.  Protein structure prediction and model quality assessment. , 2009, Drug discovery today.

[6]  Grace W. Tang,et al.  Comparative modeling: the state of the art and protein drug target structure prediction. , 2011, Combinatorial chemistry & high throughput screening.

[7]  K. Varahramyan,et al.  Glucose sensor based on organic thin film transistor using glucose oxidase and conducting polymer , 2008 .

[8]  Antti Poso,et al.  Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor. , 2005, Journal of medicinal chemistry.

[9]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[10]  Jenny Andersson,et al.  Bioactive Glass (S53P4) and Mesoporous MCM-41-Type SiO2 Adjusting In Vitro Bioactivity of Porous PDLLA , 2003 .

[11]  D. Bhandari,et al.  Recent trends in oral drug delivery: a review. , 2009, Recent patents on drug delivery & formulation.

[12]  R. Wade,et al.  Computational approaches to identifying and characterizing protein binding sites for ligand design , 2009, Journal of molecular recognition : JMR.

[13]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[14]  Matteo Masetti,et al.  Protein Flexibility in Drug Discovery: From Theory to Computation , 2015, ChemMedChem.

[15]  Sandeep Kalepu,et al.  Oral lipid-based drug delivery systems – an overview , 2013 .

[16]  Ross Cagan,et al.  Drosophila as a tool for personalized medicine: a primer. , 2010, Personalized medicine.

[17]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[18]  T. Karjalainen,et al.  Biodegradable lactone copolymers.II.Hydrolytic study of e-caprolactone and lactide copolymers , 1996 .

[19]  J. Lovrić,et al.  Nanotherapeutics in the EU: an overview on current state and future directions , 2014, International journal of nanomedicine.

[20]  S. Jalkanen,et al.  Crystal structure of the human vascular adhesion protein‐1: Unique structural features with functional implications , 2005, Protein science : a publication of the Protein Society.

[21]  Petri Ihalainen,et al.  Inkjet-printed gold electrodes on paper: characterization and functionalization. , 2012, ACS applied materials & interfaces.

[22]  Ari Rosling,et al.  In vitro degradation of porous poly(dl-lactide-co-glycolide) (PLGA)/bioactive glass composite foams with a polar structure , 2007 .

[23]  Arthur G Erdman,et al.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[24]  J. Song,et al.  Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli , 2007, Applied and Environmental Microbiology.

[25]  Jun Li,et al.  Rationally Designed Peptide Interface for Potential Modulated Cell Adhesion and Migration , 2015 .

[26]  F. Kiessling,et al.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Rebecca C Wade,et al.  The active–inactive transition of human thymidylate synthase: Targeted molecular dynamics simulations , 2011, Proteins.

[28]  Sarah Hedtrich,et al.  Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers. , 2015, Biotechnology advances.

[29]  Tiina Salminen,et al.  A peptide inhibitor of vascular adhesion protein‐1 (VAP‐1) blocks leukocyte–endothelium interactions under shear stress , 2004, European journal of immunology.

[30]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[31]  I. Sondi,et al.  Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. , 2004, Journal of colloid and interface science.

[32]  Robert Fraczkiewicz,et al.  Using Cheminformatics in Drug Discovery. , 2016, Handbook of experimental pharmacology.

[33]  Jianming Pan,et al.  Spatio‐Design of Multidimensional Prickly Zn‐Doped CuO Nanoparticle for Efficient Bacterial Killing , 2016 .

[34]  Kristiina Oksman,et al.  Electrospun chitosan-based nanocomposite mats reinforced with chitin nanocrystals for wound dressing. , 2014, Carbohydrate polymers.

[35]  Brian Dymock,et al.  Predicting chemotherapeutic drug combinations through gene network profiling , 2016, Scientific Reports.

[36]  Vinayak Sant,et al.  Graphene-based nanomaterials for drug delivery and tissue engineering. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Edwin W H Jager,et al.  Electrochemical control of growth factor presentation to steer neural stem cell differentiation. , 2011, Angewandte Chemie.

[38]  Felicitas Genze,et al.  Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer. , 2014, Nanomedicine.

[39]  Pere Roca-Cusachs,et al.  Temporary increase in plasma membrane tension coordinates the activation of exocytosis and contraction during cell spreading , 2011, Proceedings of the National Academy of Sciences.

[40]  Wim E Hennink,et al.  Cancer nanomedicines: oversold or underappreciated? , 2017, Expert opinion on drug delivery.

[41]  Jun Liu,et al.  Development of nanocellulose scaffolds with tunable structures to support 3D cell culture. , 2016, Carbohydrate polymers.

[42]  Jiashu Sun,et al.  Microfluidics-mediated assembly of functional nanoparticles for cancer-related pharmaceutical applications. , 2016, Nanoscale.

[43]  Jun Liu,et al.  A review of bioactive plant polysaccharides: Biological activities, functionalization, and biomedical applications , 2015 .

[44]  A. Francis Stewart,et al.  Technical approaches for mouse models of human disease , 2011, Disease Models & Mechanisms.

[45]  Mika Linden,et al.  Mesoporous silica nanoparticles in tissue engineering--a perspective. , 2016, Nanomedicine.

[46]  Torsten Schwede,et al.  Protein modeling: what happened to the "protein structure gap"? , 2013, Structure.

[47]  Niklas Sandler,et al.  Improvement of dissolution rate of indomethacin by inkjet printing. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  Monika Heiner,et al.  Application of Petri net theory for modelling and validation of the sucrose breakdown pathway in the potato tuber , 2005, Bioinform..

[49]  Ronald Österbacka,et al.  Application of Paper-Supported Printed Gold Electrodes for Impedimetric Immunosensor Development , 2012, Biosensors.

[50]  Shenguang Ge,et al.  Photoelectrochemical lab-on-paper device based on an integrated paper supercapacitor and internal light source. , 2013, Analytical chemistry.

[51]  Christoph A. Sotriffer,et al.  Virtual screening : principles, challenges, and practical guidelines , 2011 .

[52]  J Mitchell Guss,et al.  Structure and inhibition of human diamine oxidase. , 2009, Biochemistry.

[53]  Niklas Sandler,et al.  Inkjet printing of drug substances and use of porous substrates-towards individualized dosing. , 2011, Journal of pharmaceutical sciences.

[54]  D. Citterio,et al.  Inkjet-printed microfluidic multianalyte chemical sensing paper. , 2008, Analytical chemistry.

[55]  C. Nichols,et al.  Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery , 2011, Pharmacological Reviews.

[56]  Paul Yager,et al.  Two-dimensional paper network format that enables simple multistep assays for use in low-resource settings in the context of malaria antigen detection. , 2012, Analytical chemistry.

[57]  Kazunori Kataoka,et al.  Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling , 2007, Proceedings of the National Academy of Sciences.

[58]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[59]  Thierry F. Vandamme,et al.  Use of rodents as models of human diseases , 2014, Journal of pharmacy & bioallied sciences.

[60]  S. Bhatia,et al.  Engineering a perfusable 3D human liver platform from iPS cells. , 2016, Lab on a chip.

[61]  Jung-Hsin Lin,et al.  Scoring functions for prediction of protein-ligand interactions. , 2013, Current pharmaceutical design.

[62]  Bruno Sarmento,et al.  A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors , 2015, Nano Research.

[63]  Maria Paola Costi,et al.  Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase. , 2015, Journal of medicinal chemistry.

[64]  Petri Ihalainen,et al.  A low-cost paper-based inkjet-printed platform for electrochemical analyses , 2013 .

[65]  Jeffrey M Karp,et al.  Engineering Stem Cell Organoids. , 2016, Cell stem cell.

[66]  Young Jik Kwon,et al.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[67]  J. Justin Gooding,et al.  Recent Advances in Paper-Based Sensors , 2012, Sensors.

[68]  Jarno Salonen,et al.  Inhibition of Multidrug Resistance of Cancer Cells by Co‐Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes , 2015 .

[69]  Hélder A Santos,et al.  Multifunctional porous silicon nanoparticles for cancer theranostics. , 2015, Biomaterials.

[70]  Shiguo Chen,et al.  Integration of lysozyme into chitosan nanoparticles for improving antibacterial activity. , 2017, Carbohydrate polymers.

[71]  Jan Grimm,et al.  Will nanotechnology influence targeted cancer therapy? , 2011, Seminars in radiation oncology.

[72]  Hans Clevers,et al.  Organoids: Modeling Development and the Stem Cell Niche in a Dish. , 2016, Developmental cell.

[73]  K. Denessiouk,et al.  Activating ERBB4 mutations in non-small cell lung cancer , 2016, Oncogene.

[74]  Martin Fussenegger,et al.  Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells. , 2015, Current opinion in chemical biology.

[75]  Paul H. Johnson,et al.  pH-responsive polymeric micelle carriers for siRNA drugs. , 2010, Biomacromolecules.

[76]  Mamoru Ito,et al.  Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.

[77]  Y. Duan,et al.  Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy. , 2014, Chemical reviews.

[78]  J. Rantanen,et al.  The Future of Pharmaceutical Manufacturing Sciences , 2015, Journal of pharmaceutical sciences.

[79]  David Smith,et al.  Crystallization and preliminary X-ray analysis of the human vascular adhesion protein-1. , 2003, Acta crystallographica. Section D, Biological crystallography.

[80]  Yang Yang,et al.  Nanoparticle-based immunotherapy for cancer. , 2015, ACS nano.

[81]  Michael A Repka,et al.  Applications of hot-melt extrusion for drug delivery , 2008, Expert opinion on drug delivery.

[82]  K. Paknikar,et al.  Applications of bacterial cellulose and its composites in biomedicine , 2015, Applied Microbiology and Biotechnology.

[83]  Paula T Hammond,et al.  Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[84]  Laurent Ségalat,et al.  High‐throughput screening and small animal models, where are we? , 2010, British journal of pharmacology.

[85]  Daniel W Pack,et al.  Microspheres for controlled release drug delivery , 2004, Expert opinion on biological therapy.

[86]  Ruth Nussinov,et al.  Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.

[87]  Philippe Vayer,et al.  Toward in silico structure-based ADMET prediction in drug discovery. , 2012, Drug discovery today.

[88]  G. Whitesides,et al.  Diagnostics for the developing world: microfluidic paper-based analytical devices. , 2010, Analytical chemistry.

[89]  Trine Husøy,et al.  Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway. , 2016, Carcinogenesis.

[90]  A. Schindler,et al.  Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers , 1979 .

[91]  Hans Clevers,et al.  Organoid cultures for the analysis of cancer phenotypes. , 2014, Current opinion in genetics & development.

[92]  Nikolai Petrovsky,et al.  Carbohydrate-based immune adjuvants , 2011, Expert review of vaccines.

[93]  Martin Zacharias,et al.  Exploring biomolecular dynamics and interactions using advanced sampling methods , 2015, Journal of physics. Condensed matter : an Institute of Physics journal.

[94]  Tuomas Näreoja,et al.  Prolonged Dye Release from Mesoporous Silica-Based Imaging Probes Facilitates Long-Term Optical Tracking of Cell Populations In Vivo. , 2016, Small.

[95]  C. Doss,et al.  Molecular Dynamics: New Frontier in Personalized Medicine. , 2016, Advances in protein chemistry and structural biology.

[96]  Didem Şen Karaman,et al.  Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect. , 2015, Biomaterials science.

[97]  T. Park,et al.  Diverse Applications of Nanomedicine , 2017, ACS nano.

[98]  Mandy B. Esch,et al.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. , 2014, Lab on a chip.

[99]  Ali Khademhosseini,et al.  Organs-on-a-chip: a new tool for drug discovery , 2014, Expert opinion on drug discovery.

[100]  Petri Ihalainen,et al.  Stable ink dispersions suitable for roll-to-roll printing with sensitivity towards hydrogen sulphide gas , 2014 .

[101]  Christopher S. Chen,et al.  Biomimetic on-a-chip platforms for studying cancer metastasis. , 2016, Current opinion in chemical engineering.

[102]  Linfeng Li,et al.  High-throughput imaging: Focusing in on drug discovery in 3D. , 2016, Methods.

[103]  Tiina Salminen,et al.  Carbohydrates located on the top of the “cap” contribute to the adhesive and enzymatic functions of vascular adhesion protein‐1 , 2005, European journal of immunology.

[104]  A. Bernkop‐Schnürch,et al.  Chitosan-based drug delivery systems. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[105]  Kalle Levon,et al.  Mesoporous silica particle-PLA-PANI hybrid scaffolds for cell-directed intracellular drug delivery and tissue vascularization. , 2015, Nanoscale.

[106]  C. Coleman,et al.  Chicken embryo as a model for regenerative medicine. , 2008, Birth defects research. Part C, Embryo today : reviews.

[107]  Jennifer I. Hare,et al.  Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.

[108]  Xingde Li,et al.  Biodegradable Stimuli-Responsive Polymeric Micelles for Treatment of Malignancy. , 2016, Current pharmaceutical biotechnology.

[109]  Arto Urtti,et al.  The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells. , 2014, Stem cells and development.

[110]  Josef Hormes,et al.  Microfluidic synthesis of nanomaterials. , 2008, Small.

[111]  A. Elofsson,et al.  Structure is three to ten times more conserved than sequence—A study of structural response in protein cores , 2009, Proteins.

[112]  Jean-Luc Poyet,et al.  Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology , 2014, Molecular informatics.

[113]  Petri Ihalainen,et al.  Hierarchically structured self-supported latex films for flexible and semi-transparent electronics , 2016 .

[114]  Peng Jia,et al.  Upregulating Hif‐1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound , 2016, Advanced healthcare materials.

[115]  Brian K. Shoichet,et al.  Virtual screening of chemical libraries , 2004, Nature.

[116]  Marco Roos,et al.  The promise of a virtual lab in drug discovery. , 2006, Drug discovery today.

[117]  Manos M. Tentzeris,et al.  Passive low-cost inkjet-printed smart skin sensor for structural health monitoring , 2012 .

[118]  E. Lionta,et al.  Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances , 2014, Current topics in medicinal chemistry.

[119]  Leonard I Zon,et al.  Hooked! Modeling human disease in zebrafish. , 2012, The Journal of clinical investigation.

[120]  Madeline A. Lancaster,et al.  Dishing out mini-brains: Current progress and future prospects in brain organoid research , 2016, Developmental biology.

[121]  Cayetano Gonzalez,et al.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics , 2013, Nature Reviews Cancer.

[122]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[123]  H. Vandenburgh,et al.  High-content drug screening with engineered musculoskeletal tissues. , 2010, Tissue engineering. Part B, Reviews.

[124]  Niklas Sandler,et al.  Printing technologies in fabrication of drug delivery systems , 2013, Expert opinion on drug delivery.

[125]  Luis M. Liz-Marzán,et al.  Current Challenges toward In Vitro Cellular Validation of Inorganic Nanoparticles , 2016, Bioconjugate chemistry.

[126]  Liming Hu,et al.  Advances in chitosan-based drug delivery vehicles. , 2013, Nanoscale.

[127]  Donald Hamelberg,et al.  Enhanced molecular dynamics sampling of drug target conformations , 2016, Biopolymers.

[128]  Dietmar W. Hutmacher,et al.  Long-term effects of hydrogel properties on human chondrocyte behavior , 2010 .

[129]  Ryan C Hayward,et al.  Mimicking dynamic in vivo environments with stimuli-responsive materials for cell culture. , 2012, Trends in biotechnology.

[130]  Pauliina Kronqvist,et al.  Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[131]  G. Whitesides,et al.  Patterned paper as a platform for inexpensive, low-volume, portable bioassays. , 2007, Angewandte Chemie.

[132]  James A. Glazier,et al.  A Multi-cell, Multi-scale Model of Vertebrate Segmentation and Somite Formation , 2011, PLoS Comput. Biol..

[133]  E. Abdelhay,et al.  Genetically modified animals for use in research and biotechnology. , 2010, Genetics and molecular research : GMR.

[134]  Cato T. Laurencin,et al.  Polysaccharide biomaterials for drug delivery and regenerative engineering , 2014 .

[135]  G. Whitesides,et al.  Measuring markers of liver function using a micropatterned paper device designed for blood from a fingerstick. , 2012, Analytical chemistry.

[136]  N. Sandler,et al.  Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[137]  Mats Gyllenberg,et al.  A Bayesian molecular interaction library , 2003, J. Comput. Aided Mol. Des..

[138]  Robert Langer,et al.  Controlled release of a therapeutic protein , 1996, Nature Medicine.

[139]  Dieter Klemm,et al.  Nanocelluloses: a new family of nature-based materials. , 2011, Angewandte Chemie.

[140]  Theodora Katsila,et al.  Computational approaches in target identification and drug discovery , 2016, Computational and structural biotechnology journal.

[141]  Andreas Bender,et al.  Recognizing Pitfalls in Virtual Screening: A Critical Review , 2012, J. Chem. Inf. Model..

[142]  Ion Petre,et al.  Target Controllability of Linear Networks , 2016, CMSB.

[143]  Pauliina Kronqvist,et al.  Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms , 2011, Proceedings of the National Academy of Sciences.

[144]  E. Young Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[145]  Rebecca C Wade,et al.  Dynamics of CYP51: implications for function and inhibitor design , 2015, Journal of molecular recognition : JMR.

[146]  G. Naughton,et al.  Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. , 1997, Journal of biomedical materials research.

[147]  Jitender Verma,et al.  3D-QSAR in drug design--a review. , 2010, Current topics in medicinal chemistry.

[148]  Giridhar Thiagarajan,et al.  Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model. , 2014, Biomaterials.

[149]  Alain Dufresne,et al.  Nanocellulose in biomedicine: Current status and future prospect , 2014 .

[150]  Alpan Raval,et al.  Computational modeling in systems biology. , 2010, Methods in molecular biology.

[151]  Koen Raemdonck,et al.  Lessons in simplicity that should shape the future of drug delivery , 2015, Nature Biotechnology.

[152]  C. Tomlin,et al.  Biology by numbers: mathematical modelling in developmental biology , 2007, Nature Reviews Genetics.

[153]  Antti Poso,et al.  Identification of WIN55212‐3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor , 2005, British journal of pharmacology.

[154]  Mueez U. Din,et al.  In Vivo Imaging of Reactive Oxygen and Nitrogen Species in Murine Colitis , 2014, Inflammatory bowel diseases.

[155]  Wolfgang J Parak,et al.  Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. , 2010, Pharmacological research.

[156]  M Gyllenberg,et al.  A fragment library based on Gaussian mixtures predicting favorable molecular interactions. , 2001, Journal of molecular biology.

[157]  Friedrich Rippmann,et al.  Perturbation Approaches for Exploring Protein Binding Site Flexibility to Predict Transient Binding Pockets. , 2016, Journal of chemical theory and computation.

[158]  K. Lee,et al.  Injectable microsphere/hydrogel combination systems for localized protein delivery. , 2009, Macromolecular bioscience.

[159]  Ali Jazayeri,et al.  From G Protein-coupled Receptor Structure Resolution to Rational Drug Design* , 2015, The Journal of Biological Chemistry.

[160]  Christie M. Sayes,et al.  Nanomaterial Drug Products: Manufacturing and Analytical Perspectives , 2016, The AAPS Journal.

[161]  Giulio Rastelli,et al.  Exploiting computationally derived out-of-the-box protein conformations for drug design. , 2016, Future medicinal chemistry.

[162]  Yeong-Der Yao,et al.  The effects of gold nanoparticles in wound healing with antioxidant epigallocatechin gallate and α-lipoic acid. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[163]  Ashish Ranjan Sharma,et al.  Zebrafish: A complete animal model to enumerate the nanoparticle toxicity , 2016, Journal of Nanobiotechnology.

[164]  Elena Aznar,et al.  Gated Materials for On-Command Release of Guest Molecules. , 2016, Chemical reviews.

[165]  Stephan Daus,et al.  Xylan-based nanoparticles: prodrugs for ibuprofen release. , 2010, Macromolecular bioscience.

[166]  F. Collins,et al.  The path to personalized medicine. , 2010, The New England journal of medicine.

[167]  H. Clevers,et al.  Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications , 2013, Science.

[168]  Suzanne Skolnik,et al.  Permeability diagnosis model in drug discovery: a diagnostic tool to identify the most influencing properties for gastrointestinal permeability. , 2013, Current topics in medicinal chemistry.

[169]  Petri Ihalainen,et al.  Biocompatibility of printed paper-based arrays for 2-D cell cultures. , 2013, Acta biomaterialia.

[170]  Philipp J. Keller,et al.  Reconstruction of Zebrafish Early Embryonic Development by Scanned Light Sheet Microscopy , 2008, Science.

[171]  M. Busquets,et al.  Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents , 2015, International journal of nanomedicine.

[172]  Hyejin Park,et al.  Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications. , 2012, Journal of biomedical materials research. Part A.

[173]  Petri Ihalainen,et al.  Enhanced protein adsorption and patterning on nanostructured latex-coated paper. , 2014, Colloids and surfaces. B, Biointerfaces.

[174]  B. Palsson,et al.  The model organism as a system: integrating 'omics' data sets , 2006, Nature Reviews Molecular Cell Biology.

[175]  Muhammad Mustafa Abeer,et al.  A review of bacterial cellulose‐based drug delivery systems: their biochemistry, current approaches and future prospects , 2014, The Journal of pharmacy and pharmacology.

[176]  Jessica M. Rosenholm,et al.  Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier , 2016, PloS one.

[177]  Mutsumi Takagi,et al.  Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytes. , 2005, Journal of bioscience and bioengineering.

[178]  Pedro J Ballester,et al.  Machine‐learning scoring functions to improve structure‐based binding affinity prediction and virtual screening , 2015, Wiley interdisciplinary reviews. Computational molecular science.

[179]  Jun Liu,et al.  Hemicellulose-reinforced nanocellulose hydrogels for wound healing application , 2016, Cellulose.

[180]  Hélder A Santos,et al.  Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. , 2013, Biomaterials.

[181]  Martti Toivakka,et al.  A multilayer coated fiber-based substrate suitable for printed functionality , 2009 .

[182]  G Wayne Brodland,et al.  How computational models can help unlock biological systems. , 2015, Seminars in cell & developmental biology.

[183]  T. Misgeld,et al.  Super-resolution microscopy writ large , 2016, Nature Biotechnology.

[184]  Antti Poso,et al.  Development of a 3D model for the human cannabinoid CB1 receptor. , 2004, Journal of medicinal chemistry.

[185]  Robert Gurny,et al.  The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. , 2007, Advanced drug delivery reviews.

[186]  Fiona Regan,et al.  The use of nanoparticles in anti-microbial materials and their characterization. , 2008, The Analyst.

[187]  Hari Singh Nalwa,et al.  Handbook of surfaces and interfaces of materials , 2001 .

[188]  Klaus Elenius,et al.  Somatic Mutations of ErbB4 , 2009, Journal of Biological Chemistry.

[189]  M. Yousaf,et al.  Redox-switchable surface for controlling peptide structure. , 2011, Journal of the American Chemical Society.

[190]  Kaizheng Zhu,et al.  Zebrafish as a model system for characterization of nanoparticles against cancer. , 2016, Nanoscale.

[191]  D. Huh,et al.  Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.

[192]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[193]  Cheng Luo,et al.  In silico ADME/T modelling for rational drug design , 2015, Quarterly Reviews of Biophysics.

[194]  Maya Thanou,et al.  RSC Polymer Chemistry Series , 2011 .

[195]  G. Klebe Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[196]  M. S. Johnson,et al.  Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. , 1998, Protein engineering.

[197]  R. W. Gracy,et al.  In vivo degradation of oxidized, regenerated cellulose. , 1990, Carbohydrate research.

[198]  Jun Liu,et al.  Biocomposites of nanofibrillated cellulose, polypyrrole, and silver nanoparticles with electroconductive and antimicrobial properties. , 2014, Biomacromolecules.

[199]  L. Lucia,et al.  Cellulose nanocrystals: chemistry, self-assembly, and applications. , 2010, Chemical reviews.

[200]  Liju Yang,et al.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.

[201]  N. Foloppe,et al.  Towards predictive ligand design with free-energy based computational methods? , 2006, Current medicinal chemistry.

[202]  Alexandru Al. Ecovoiu,et al.  Drosophotoxicology: An Emerging Research Area for Assessing Nanoparticles Interaction with Living Organisms , 2016, International journal of molecular sciences.

[203]  Ali Khademhosseini,et al.  3D biofabrication strategies for tissue engineering and regenerative medicine. , 2014, Annual review of biomedical engineering.

[204]  Maren Preis,et al.  Thin substrates manufactured by means of 3D-printing for tailor-made drug delivery systems , 2016 .

[205]  Jaehong Key,et al.  Nanoparticles for multimodal in vivo imaging in nanomedicine , 2014, International journal of nanomedicine.

[206]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[207]  Wim E Hennink,et al.  Hydrogels for protein delivery. , 2012, Chemical reviews.

[208]  L. Rahme,et al.  Drosophila melanogaster as a model for human intestinal infection and pathology , 2011, Disease Models & Mechanisms.

[209]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[210]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[211]  Cecilia Sahlgren,et al.  Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[212]  Thomas C. Ferrante,et al.  Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro , 2015, Nature Methods.

[213]  Shan Jiang,et al.  Oral Administration and Selective Uptake of Polymeric Nanoparticles in Drosophila Larvae as an in Vivo Model. , 2015, ACS biomaterials science & engineering.

[214]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[215]  Akira Isogai,et al.  TEMPO-oxidized cellulose nanofibers. , 2011, Nanoscale.

[216]  Chad A. Mirkin,et al.  Drivers of biodiagnostic development , 2009, Nature.

[217]  Jessica M. Rosenholm,et al.  Current Approaches for Exploration of Nanoparticles as Antibacterial Agents , 2017 .

[218]  Abdul Ghaffar,et al.  Injectable biopolymer based hydrogels for drug delivery applications. , 2015, International journal of biological macromolecules.

[219]  Dragos Horvath,et al.  Pharmacophore-based virtual screening. , 2011, Methods in molecular biology.

[220]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[221]  Kunal Pal,et al.  Chitosan Based Delivery Systems on a Length Scale: Nano to Macro , 2013 .

[222]  Anthony P F Turner,et al.  Tutorial Review : Biosensors: sense and sensibility , 2013 .

[223]  Aurélien Naldi,et al.  Diversity and Plasticity of Th Cell Types Predicted from Regulatory Network Modelling , 2010, PLoS Comput. Biol..

[224]  Ari Rosling,et al.  Drug Release from Poly(D, L-Lactide) / SiO2 Composites , 2003 .

[225]  Albert-László Barabási,et al.  Target control of complex networks , 2014, Nature Communications.

[226]  Jarno Salonen,et al.  Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy. , 2015, Biomaterials.

[227]  Maren Preis,et al.  Oromucosal film preparations: points to consider for patient centricity and manufacturing processes , 2016, Expert opinion on drug delivery.

[228]  B. Baroli,et al.  Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? , 2010, Journal of pharmaceutical sciences.

[229]  Pochert Alexander,et al.  定量的~19F磁気共鳴イメージングにより研究した中空メソ多孔性シリカナノ粒子の生体内分布に及ぼす貨物の影響【Powered by NICT】 , 2017 .

[230]  Maria Paola Costi,et al.  Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase , 2011, Proceedings of the National Academy of Sciences.

[231]  Vincent M. Rotello,et al.  Functional Gold Nanoparticles as Potent Antimicrobial Agents against Multi-Drug-Resistant Bacteria , 2014, ACS nano.

[232]  Maren Preis,et al.  Printed Drug-Delivery Systems for Improved Patient Treatment. , 2016, Trends in pharmacological sciences.

[233]  Antti Poso,et al.  Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. , 2006, Journal of medicinal chemistry.

[234]  Maddaly Ravi,et al.  3D Cell Culture Systems: Advantages and Applications , 2015, Journal of cellular physiology.

[235]  Leonard I Zon,et al.  Of fish and men: using zebrafish to fight human diseases. , 2013, Trends in cell biology.

[236]  Gustavo de Medeiros,et al.  Light-sheet imaging of mammalian development. , 2016, Seminars in cell & developmental biology.

[237]  Emilio Benfenati,et al.  Comparison of In Silico Models for Prediction of Mutagenicity , 2013, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[238]  K. Wong,et al.  Topical Delivery of Silver Nanoparticles Promotes Wound Healing , 2007, ChemMedChem.

[239]  Richard M Crooks,et al.  Paper-based electrochemical sensing platform with integral battery and electrochromic read-out. , 2012, Analytical chemistry.

[240]  Albert-László Barabási,et al.  Controllability of complex networks , 2011, Nature.

[241]  Antti Poso,et al.  3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. , 2006, Journal of medicinal chemistry.

[242]  Käthe M. Dahlström,et al.  3D model for Cancerous Inhibitor of Protein Phosphatase 2A armadillo domain unveils highly conserved protein-protein interaction characteristics. , 2015, Journal of theoretical biology.

[243]  Donald E. Ingber,et al.  Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip , 2016, PloS one.

[244]  Ronald Österbacka,et al.  An impedimetric study of DNA hybridization on paper-supported inkjet-printed gold electrodes , 2014, Nanotechnology.

[245]  Meritxell Huch,et al.  Organoids from adult liver and pancreas: Stem cell biology and biomedical utility. , 2016, Developmental biology.

[246]  Ferenc Fülöp,et al.  Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode. , 2013, Journal of medicinal chemistry.

[247]  Gabriele Cruciani,et al.  Molecular fields in drug discovery: getting old or reaching maturity? , 2010, Drug discovery today.

[248]  Luca Cardelli,et al.  A Peptide Filtering Relation Quantifies MHC Class I Peptide Optimization , 2011, PLoS Comput. Biol..

[249]  D. Beebe,et al.  The present and future role of microfluidics in biomedical research , 2014, Nature.

[250]  Chuang Lu,et al.  Preclinical experimental models of drug metabolism and disposition in drug discovery and development , 2012 .

[251]  Erich E Hoover,et al.  Advances in multiphoton microscopy technology , 2013, Nature Photonics.

[252]  T. Blundell,et al.  Knowledge-based protein modeling. , 1994, Critical reviews in biochemistry and molecular biology.

[253]  Denis Thieffry,et al.  Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision , 2013, PLoS Comput. Biol..

[254]  Ruth Nussinov,et al.  Druggable orthosteric and allosteric hot spots to target protein-protein interactions. , 2014, Current pharmaceutical design.

[255]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[256]  John B. O. Mitchell,et al.  Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies , 2016, Front. Neurosci..

[257]  Mihail C. Roco,et al.  Nano on reflection. , 2016, Nature nanotechnology.

[258]  Tiina A. Salminen,et al.  Stereoselective Oxidation of Aryl-Substituted Vicinal Diols into Chiral α-Hydroxy Aldehydes by Re-Engineered Propanediol Oxidoreductase , 2013 .

[259]  D. LeMaster,et al.  Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design. , 2015, Current molecular pharmacology.

[260]  Käthe M. Dahlström,et al.  Substrate scope and selectivity in offspring to an enzyme subjected to directed evolution , 2014, The FEBS journal.

[261]  N. Elvassore,et al.  Functional differentiation of human pluripotent stem cells on a chip , 2015, Nature Methods.

[262]  R. Jalil,et al.  Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.

[263]  S. Jalkanen,et al.  A cell surface amine oxidase directly controls lymphocyte migration. , 2001, Immunity.

[264]  Daniel C Leslie,et al.  A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.

[265]  G. Plosker,et al.  Bilayered Bioengineered Skin Substitute (Apligraf®) , 2012, BioDrugs.

[266]  Eric R. Blough,et al.  Nanomedicine in drug delivery , 2013 .

[267]  Brian K Shoichet,et al.  Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. , 2006, Journal of medicinal chemistry.

[268]  Daniel Moser,et al.  Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering. , 2012, ACS medicinal chemistry letters.

[269]  Didem Şen Karaman,et al.  Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles , 2016, International journal of nanomedicine.

[270]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[271]  Käthe M. Dahlström,et al.  Deciphering tissue-induced Klebsiella pneumoniae lipid A structure , 2015, Proceedings of the National Academy of Sciences.

[272]  M Gribskov,et al.  A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. , 2001, Genome research.

[273]  Aaron J. Bell,et al.  Flies as the ointment: Drosophila modeling to enhance drug discovery , 2009, Fly.

[274]  Ari Rosling,et al.  Calcium phosphate formation and ion dissolution rates in silica gel-PDLLA composites. , 2003, Biomaterials.

[275]  Aida Habtezion,et al.  Reactive Oxygen Species Imaging in a Mouse Model of Inflammatory Bowel Disease , 2016, Molecular Imaging and Biology.

[276]  Jarno Salonen,et al.  Fabrication of a Multifunctional Nano‐in‐micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix , 2014, Advanced materials.

[277]  Kuan-Chung Chen,et al.  Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer , 2014, Evidence-based complementary and alternative medicine : eCAM.

[278]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[279]  Jukka Corander,et al.  Probabilistic Prediction of Contacts in Protein-Ligand Complexes , 2012, PloS one.

[280]  Elisabetta Moroni,et al.  The Dynamics of Drug Discovery. , 2015, Current topics in medicinal chemistry.

[281]  Mohamed Salama,et al.  Synthesis, characterization, and antimicrobial properties of copper nanoparticles , 2013, International journal of nanomedicine.

[282]  Parvez Alam,et al.  Bacterial cellulose–kaolin nanocomposites for application as biomedical wound healing materials , 2013 .

[283]  Robert Langer,et al.  Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. , 2013, ACS nano.

[284]  Laurent Lévy Europe as leaders in nanomedicine: let's go for it! , 2014, Nanomedicine.

[285]  Volker Rasche,et al.  Cargo-influences on the biodistribution of hollow mesoporous silica nanoparticles as studied by quantitative 19F-magnetic resonance imaging. , 2017, Journal of colloid and interface science.

[286]  Chung F. Wong,et al.  Flexible receptor docking for drug discovery , 2015, Expert opinion on drug discovery.

[287]  Leonardo L. G. Ferreira,et al.  Molecular Docking and Structure-Based Drug Design Strategies , 2015, Molecules.

[288]  Ying Zhang,et al.  Advanced materials and processing for drug delivery: the past and the future. , 2013, Advanced drug delivery reviews.

[289]  Petri Ihalainen,et al.  Paper-based planar reaction arrays for printed diagnostics , 2011 .

[290]  Thomas Geisler,et al.  Automated live cell screening system based on a 24-well-microplate with integrated micro fluidics , 2007, Medical & Biological Engineering & Computing.

[291]  Donald E Ingber,et al.  Reverse Engineering Human Pathophysiology with Organs-on-Chips , 2016, Cell.

[292]  Markku S Kulomaa,et al.  Rational Modification of Ligand‐Binding Preference of Avidin by Circular Permutation and Mutagenesis , 2008, Chembiochem : a European journal of chemical biology.

[293]  Bridget E. Begg,et al.  A Proteome-Scale Map of the Human Interactome Network , 2014, Cell.

[294]  Antonietta Gatti,et al.  Cytotoxicity tests of cellulose nanofibril-based structures , 2013, Cellulose.

[295]  D. Kohane,et al.  HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .

[296]  David J Smith,et al.  Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3. , 2011, Biochemistry.

[297]  Henri Xhaard,et al.  Coordination of Na+ by Monoamine Ligands in Dopamine, Norepinephrine, and Serotonin Transporters , 2008, J. Chem. Inf. Model..

[298]  Buddy D. Ratner,et al.  Biomolecules and surfaces , 1990 .

[299]  I. Lakatos,et al.  Colloids Surfaces A: Physicochem , 1998 .

[300]  A. Fiser Template-based protein structure modeling. , 2010, Methods in molecular biology.

[301]  Vimal Parkash,et al.  Structural comparison of the active site channels in rodent and primate vascular adhesion protein-1 , 2013, Journal of Neural Transmission.

[302]  Sujan Dutta,et al.  Temperature, pH and redox responsive cellulose based hydrogels for protein delivery. , 2016, International journal of biological macromolecules.

[303]  M. Leite,et al.  Surface biofunctionalized CdS and ZnS quantum dot nanoconjugates for nanomedicine and oncology: to be or not to be nanotoxic? , 2016, International journal of nanomedicine.

[304]  Niklas Sandler,et al.  Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[305]  Yaakov Nahmias,et al.  Long-term culture and coculture of primary rat and human hepatocytes. , 2013, Methods in molecular biology.

[306]  P. Prusis,et al.  Melanocortin Receptors: Ligands and Proteochemometrics Modeling , 2003, Annals of the New York Academy of Sciences.

[307]  George M Whitesides,et al.  Integration of paper-based microfluidic devices with commercial electrochemical readers. , 2010, Lab on a chip.

[308]  Patrick Carrier,et al.  Characterization of wound reepithelialization using a new human tissue-engineered corneal wound healing model. , 2008, Investigative ophthalmology & visual science.

[309]  J. Vinšová,et al.  Recent advances in drugs and prodrugs design of chitosan. , 2008, Current pharmaceutical design.

[310]  L. Kavraki,et al.  Understanding the challenges of protein flexibility in drug design , 2015, Expert opinion on drug discovery.

[311]  Ali Hebeish,et al.  Novel chitin/chitosan-glucan wound dressing: Isolation, characterization, antibacterial activity and wound healing properties. , 2016, International journal of pharmaceutics.

[312]  Henry Lin,et al.  Structure-based discovery of opioid analgesics with reduced side effects , 2016, Nature.

[313]  P. Chakrabarti,et al.  Shape engineering boosts antibacterial activity of chitosan coated mesoporous silica nanoparticle doped with silver: a mechanistic investigation. , 2016, Journal of materials chemistry. B.

[314]  Xu Li,et al.  A perspective on paper-based microfluidics: Current status and future trends. , 2012, Biomicrofluidics.

[315]  N. Benvenisty,et al.  Pluripotent stem cells in disease modelling and drug discovery , 2016, Nature Reviews Molecular Cell Biology.

[316]  Gabriela A Silva,et al.  Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.

[317]  Hans Clevers,et al.  Modeling Development and Disease with Organoids , 2016, Cell.

[318]  Niklas Sandler,et al.  Towards fabrication of 3D printed medical devices to prevent biofilm formation. , 2014, International journal of pharmaceutics.

[319]  Andrew Emili,et al.  Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. , 2014, ACS nano.

[320]  Matthias Gutekunst,et al.  Three‐dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo , 2014, Biotechnology journal.

[321]  Raj Bawa,et al.  Handbook of Clinical Nanomedicine : Law, Business, Regulation, Safety, and Risk , 2016 .

[322]  G Gregoriadis,et al.  The carrier potential of liposomes in biology and medicine (second of two parts). , 1976, The New England journal of medicine.

[323]  Robert Langer,et al.  An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease , 2015, Science Translational Medicine.